IP Library › Granted Patent US 9,091,698
Granted Patent B2
US 9,091,698 · App. 14/203,367 · Granted Jul 28, 2015

Advanced detection of sepsis

Inventors: Song Shi (Reisterstown, MD); Richard L. Moore (Glenville, PA); James Garrett (Baltimore, MD)
Assignee: Becton, Dickinson and Company
G01N33/74G01N33/92G01N2333/90209G01N2333/91051G01N2800/26
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,091,698
App. No.
14/203,367
Granted
Jul 28, 2015
Kind
B2
Abstract

The present invention relates to methods, monitors and systems, useful, for example, for advanced detection of sepsis in a subject.

Claims (15)

1. A method for the advanced detection of sepsis in a SIRS-positive subject, comprising the steps of:

(a) measuring at a plurality of time points, prior to laboratory confirmation of a clinically significant infection causative of sepsis, an amount of procalcitonin in fluid or tissue of the subject; and

(b) measuring at a plurality of time points, prior to laboratory confirmation of a clinically significant infection causative of sepsis, one or more clinical markers of the subject, to detect sepsis in the subject;

wherein an increase in the amount of procalcitonin from a previous amount over a 24 hour interval detects sepsis in the subject.

2. The method of claim 1 , wherein the one or more clinical marker(s) are selected from the group consisting of respiratory rate, body temperature, heart rate, systolic blood pressure, diastolic blood pressure, mean artery pressure, white blood cell count, monocyte count, lymphocyte count, granulocyte count, neutrophil count, immature neutrophil to total neutrophil ratio, platelet count, serum creatinine concentration, urea concentration, lactate concentration, glucose concentration, base excess, pO 1 and HCO 3 − concentration.

3. The method of claim 2 , wherein one clinical marker is measured.

4. The method of claim 3 , wherein respiratory rate is measured.

5. The method of claim 2 , wherein two or more clinical markers are measured.

6. The method of claim 5 , wherein respiratory rate and body temperature are measured.

7. The method of claim 1 , wherein the advanced detection is at least 12 hours prior to the onset of sepsis.

8. The method of claim 2 , wherein a body temperature greater than 38° C. detects sepsis.

9. The method of claim 2 , wherein a body temperature less than 36° C. detects sepsis.

10. The method of claim 2 , wherein a respiratory rate greater than 20 breaths per minute detects sepsis.

11. The method of claim 1 , wherein the amount is measured by spectrometry, chromatography, immunoassay, electrophoresis or enzymatic assay.

12. The method of claim 1 , wherein the fluid or tissue is blood, plasma, saliva, serum, sputum, urine, cells, cellular extract or tissue biopsy.

Continuity (3)
Continuation 12935727
Provisional Application 61123071 · Apr 3, 2008
Related Publication 20140302533A1 · Oct 9, 2014